53BP2 Antibody, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP177907-Each-of-1 | In Stock | ₹ 59,630.00 |
NBP177907 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 59,630.00
GST (18%): ₹ 10,733.40
Total Price: ₹ 70,363.40
Antigen
53BP2
Classification
Polyclonal
Conjugate
Unconjugated
Formulation
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 with 0.01% Sodium Azide
Gene Alias
apoptosis-stimulating protein of p53, 2, ASPP2P53BP2,53BP2apoptosis-stimulating of p53 protein 2, Bbp, Bcl2-binding protein, p53-binding protein 2, p53BP2, PPP1R13A, Renal carcinoma antigen NY-REN-51, tumor protein p53 binding protein, 2, tumor protein p53-binding protein, 2, Tumor suppressor p53-binding protein 2
Host Species
Rabbit
Molecular Weight of Antigen
125.62 kDa
Quantity
0.1 mg
Research Discipline
Apoptosis, Cancer, DNA Repair, Tumor Suppressors
Gene ID (Entrez)
7159
Target Species
Human, Canine, Monkey
Form
Purified
Applications
Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin)
Concentration
2.4 mg/ml
Dilution
Western Blot 1:500-1:3000, ELISA 1:2500-1:10000, Immunohistochemistry 1:10-1:500, Immunohistochemistry-Paraffin 1:10-1:500
Gene Accession No.
Q13625
Gene Symbols
TP53BP2
Immunogen
This affinity purified 53BP2 Antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to an internal sequence of human 53BP2. (Uniprot: Q13625)
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Test Specificity
This Protein A purified antibody is directed against human 53BP2. Minimal reactivity occurs against ASPP1.
Content And Storage
Store at -20°C short term. Aliquot and store at -80°C long term. Avoid freeze-thaw cycles.
Isotype
IgG
Related Products
Description
- 53BP2 Polyclonal specifically detects 53BP2 in Human samples
- It is validated for Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin.